Pharming Group N.V. (PHAR) Total Assets by Year
Pharming Group N.V. closed fiscal year 2025 with $500.0M in total assets, $222.9M in total liabilities and $277.1M in shareholder equity. Total assets rose 25.0% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Pharming Group N.V. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PHAR Balance Sheet by Fiscal Year
Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2520-F | FY2420-F | FY2320-F | FY2220-F | FY2120-F | FY2020-F | FY1920-F |
|---|---|---|---|---|---|---|---|
| Total Assets | $500.0M+25.0% | $400.0M-13.6% | $462.9M+8.7% | $425.8M+7.2% | $397.3M-5.1% | $418.5M+63.5% | $255.9M |
| Total Liabilities | $222.9M+24.6% | $178.9M-26.7% | $244.1M+10.4% | $221.2M+8.2% | $204.4M-13.0% | $235.0M+69.7% | $138.5M |
| Total Equity | $277.1M+25.4% | $221.1M+1.0% | $218.8M+6.9% | $204.6M+6.1% | $192.9M+5.2% | $183.4M+56.3% | $117.4M |
PHAR Balance Sheet by Quarter
Figures are in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F | Q4'2320-F | Q4'2220-F | Q4'2120-F | Q4'2020-F | Q4'1920-F |
|---|---|---|---|---|---|---|---|
| Total Assets | $500.0M+25.0% | $400.0M-13.6% | $462.9M+8.7% | $425.8M+7.2% | $397.3M-5.1% | $418.5M+63.5% | $255.9M |
| Total Liabilities | $222.9M+24.6% | $178.9M-26.7% | $244.1M+10.4% | $221.2M+8.2% | $204.4M-13.0% | $235.0M+69.7% | $138.5M |
| Total Equity | $277.1M+25.4% | $221.1M+1.0% | $218.8M+6.9% | $204.6M+6.1% | $192.9M+5.2% | $183.4M+56.3% | $117.4M |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Pharming Group N.V. financials
Frequently Asked Questions
Pharming Group N.V. closed fiscal year 2025 with $500.0M in total assets, $222.9M in total liabilities and $277.1M in shareholder equity.
Pharming Group N.V. (PHAR) total assets rose by 25.0% year over year, from $400.0M to $500.0M in fiscal year 2025.
Across the 7 fiscal years this page covers, Pharming Group N.V. (PHAR) total assets went from $255.9M in fiscal year 2019 to $500.0M in fiscal year 2025.
Pharming Group N.V. (PHAR) reported $500.0M in total assets in Q4 2025. This represents an increase of 25.0% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Pharming Group N.V. (PHAR) reported on that line in every period on record.